Intelligent Bio Solutions (INBS) announced it has integrated Arabic as the second international language to its Intelligent Fingerprinting Drug Screening, IFDS, System as part of the Company’s multilingual upgrade. The addition of Arabic follows INBS’s previously announced expansion plans in the Middle East in early 2025, through its partnership with Ivy Diagnostics. Arabic is spoken by approximately 450 million people worldwide, holding official status in nearly 25 countries1. With this update, INBS is making its technology more accessible to Arabic-speaking organizations in safety-critical industries, law enforcement and drug rehabilitation, reinforcing its presence in the Middle East and capitalizing on the growing global demand for innovative drug testing solutions.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBS:
- Intelligent Bio Solutions to highlight drug testing tech at 2025 NDASA
- Intelligent Bio Solutions announces strategic partnership in Spain, Andorra
- Intelligent Bio Solutions Secures U.S. Patent for Drug Screening
- Intelligent Bio Solutions secures U.S. patent, strengthening IP protection
- Intelligent Bio FDA clearance process remains on track for 2025 U.S. launch